rs199473684, GLA;RPL36A-HNRNPH2
N. diseases: 3
Source: CLINVAR ×
Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease. | 28430823 | 2017 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Genetic epidemiological study doesn't support GLA IVS4+919G>A variant is a significant mutation in Fabry disease. | 28377241 | 2017 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy. | 27554049 | 2017 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease. | 28082092 | 2017 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer. | 27595546 | 2016 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation. | 27931613 | 2016 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation. | 23109060 | 2013 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations. | 22437327 | 2012 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Transposable elements in disease-associated cryptic exons. | 19823873 | 2010 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A). | 20821055 | 2010 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). | 19621417 | 2009 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. | 20031620 | 2009 | |||||
Hypertrophic Cardiomyopathy
|
0.700 | CausalMutation | CLINVAR | Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. | 11828341 | 2002 |